Animal Assisted Therapy Intervention for Hospitalized Patients in a Tertiary Care Center

NCT02959632 | Completed

• 1 other identifier: 16-007730
• Study Type: interventional
• Target: 21
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to evaluate the common symptoms leading to an Animal Assisted Therapy consult, and to measure its (AAT) influence on the symptoms and feelings of hospitalized patients.

Conditions

Hospitalized Patients

Outcome Measures

Primary Outcomes (1)

• Number of patients scoring improvement of symptoms using the VAS (visual analogue scale)

  We will record the number of patients scoring improvement of symptoms using the VAS (visual analogue scale).

  Baseline to 45 minutes

Secondary Outcomes (1)

• Number of patients scoring improvement of feelings using the VAS (visual analogue scale)

  Baseline to 45 minutes

Study Arms (1)

Patients receiving AAT

EXPERIMENTAL

Hospitalized patients receiving Animal Assisted Therapy (AAT). Animal Assisted Therapy (Pet Visit) will be provided to the hospitalized patients.

Behavioral: Animal Assisted Therapy

Interventions

Animal Assisted Therapy BEHAVIORAL

Animal Assisted Therapy is the program where a pet, usually dog will visit and interact with the patients.

Patients receiving AAT

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients admitted to St Mary's or Methodist Hospital and subsequently referred for AAT.
• Subjects undergoing Animal Assisted Therapy as part of their standard care.
• Patients 18-80 years of age.
• Patients who are able to read and answer pre and post intervention survey questionnaire and satisfaction survey.
• Care team members of the study participants.
• years of age.
• Who are able to read and answer pre and post intervention survey questionnaire and satisfaction survey.

You may not qualify if:

• Patients with diagnoses of bipolar disorder, schizophrenia or dementia.
• Unable to give consent.
• Pregnant women (as verbalized by participant).
• Care team members of the study participants who do not want to participate.

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55901, United States

Location

Related Links

• Mayo Clinic Clinical Trials

MeSH Terms

Interventions

Animal Assisted Therapy

Intervention Hierarchy (Ancestors)

Rehabilitation; Aftercare; Continuity of Patient Care; Patient Care; Therapeutics; Physical Therapy Modalities; Psychotherapy; Behavioral Disciplines and Activities; Health Services; Health Care Facilities Workforce and Services

Study Officials

• Brent A Bauer, MD

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: November 4, 2016
• First Posted: November 9, 2016
• Study Start: November 1, 2016
• Primary Completion: July 30, 2020
• Study Completion: July 30, 2020
• Last Updated: February 2, 2021

Record last verified: 2021-01

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)